Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: Results of a clinical study

BMC Ophthalmology

Volumn 7, Issue , 2007, Pages

  Rolando, Maurizio ^a   Valente, Cristiana ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYALISTIL; HYALURONIC ACID; MUCIN 1; POLYSACCHARIDE; TAMARIND SEED POLYSACCHARIDE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLINKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DRUG ACTIVITY; DRUG RETENTION; DRUG STRUCTURE; DRUG TOLERABILITY; DRY EYE; EYE BURNING; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; STAINING; TEAR FILM; VISUAL ANALOG SCALE; AGED; CHEMISTRY; DRUG ADMINISTRATION; DRUG EFFECT; INTRAOCULAR PRESSURE; LACRIMAL FLUID; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; PLANT SEED; TAMARIND;

ADULT; AGED; AGED, 80 AND OVER; CONJUNCTIVA; CORNEA; DRUG ADMINISTRATION SCHEDULE; DRY EYE SYNDROMES; FEMALE; HUMANS; HYALURONIC ACID; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PHYTOTHERAPY; POLYSACCHARIDES; SEEDS; STAINING AND LABELING; TAMARINDUS; TEARS;

EID: 34247628392     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-7-5     Document Type: Article

References (15)

1. Human lacrimal gland mucins. F Paulsen G Langer W Hoffmann M Berry, Cell Tissue Res 2004 316 167 177 10.1007/s00441-004-0877-7 15052468
2. The diagnosis and management of dry eye: a twenty-five-year review. SC Pflugfelder A Solomon ME Stern, Cornea 2000 19 644 649 10.1097/00003226- 200009000-00009 11009316
3. Physical chemistry of the normal and disordered tear film. FJ Holly, Trans Ophthalmol Soc UK 1985 104 374 380 3862270
4. Mechanism of tear film rupture and its implications for contact lens tolerance. A Sharma E Ruckenstein, Am J Optom Physiol Opt 1985 62 246 253 3993732
5. Distribution of mucins at the ocular surface. IK Gipson, Exp Eye Res 2004 78 379 388 10.1016/S0014-4835(03)00204-5 15106916
6. Epithelial mucins of the ocular surface: structure, biosynthesis and function. P Argueso IK Gipson, Exp Eye Res 2001 73 281 289 10.1006/exer.2001. 1045 11520103
7. Luciani: International patent application PCT/IT97/00026. M Saettone E Burgalassi P Boldrini G Bianchini, 1997 9528170
8. Use of a new lachrymal substitute (T S Polysaccharide) in Contactology. LL Mannucci I Fregona A Di Gennaro, J Med Contactology and Low Vision 2000 1 1 6-9.-9
9. Aspetti della cristallizzazione di differenti sostituti lacrimali in uso in Contattologia. LL Mannucci I Fregona A Mannucci, EuVision Superficie Oculare 2004 1 04 6 11
10. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. S Burgalassi L Panichi P Chetoni MF Saettone E Boldrini, Ophthalmic Res 1999 31 229 235 10.1159/000055537 10224507
11. B Lindsay, J Pharm Pharmacol 2000 Suppl 54 37
12. Study approval. " Studio Randomizzato controllato in aperto sulla attività del TS-Polisaccaride 0.5% e 1% vs. acido ialuronico 0.2% nel trattamento della sindrome dell'occhio secco". Ethics Committee of S. Martino Hospital GenoaItaly, protocol # FAR-195 - 18/03/02.
13. Tear fluid influence on the ocular surface. SC Pflugfelder, Adv Exp Med Biol 1998 438 611 617 9634944
14. http://www.eyeworld.org/article.php?sid=2553
15. The use of vital dyes in corneal disease. J Kim, Current Opinion in Ophthalmology 2000 11 241 247 10.1097/00055735-200008000-00005 10977768